Listed

Nutex Health Inc.: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Apr 15, 2015 and accepted by EDGAR at Apr 15, 2015, 09:15 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2014-01-01 to 2014-12-31$1.1mus-gaap:SalesRevenueNet
Cost of revenue12 months2014-01-01 to 2014-12-31$465.3kus-gaap:CostOfRevenue
Gross profit12 months2014-01-01 to 2014-12-31$603.3kus-gaap:GrossProfit
Operating income12 months2014-01-01 to 2014-12-31−$780.4kus-gaap:OperatingIncomeLoss
Interest expense12 months2014-01-01 to 2014-12-31−$10.3kus-gaap:InterestExpense
Net income12 months2014-01-01 to 2014-12-31−$684.3kus-gaap:NetIncomeLoss
Diluted EPS12 months2014-01-01 to 2014-12-31−$0.03us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)12 months2014-01-01 to 2014-12-3127,373,471 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2014-01-01 to 2014-12-31$165.8kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2014-01-01 to 2014-12-31−$2.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-12-31$133.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$260.2kus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$280.8kus-gaap:Assets
Current liabilitiesAt period end2014-12-31$285.3kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-12-31−$4.5kus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001211524-15-000040. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.